Developing pharmaceuticals efficiently with artificial intelligence

Ken Mulvany, Founder and Chairman of UK-firm BenevolentAI, predicts as much as 60% time saving in early drug development phases compared to traditional pharmaceutical industry averages.


GUTE-URLS

Wordpress is loading infos from co

Please wait for API server guteurls.de to collect data from
www.ibtimes.co.uk/developing-pha...